A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...
Researchers from Liverpool School of Tropical Medicine (LSTM) have completed a Phase I clinical trial for a new oral ...
1d
TipRanks on MSNMoonLake Immunotherapeutics Advances Clinical Trials in 2024Moonlake Immunotherapeutics ( ($MLTX) ) has released its Q4 earnings. Here is a breakdown of the information Moonlake Immunotherapeutics presented ...
Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine.
9d
News-Medical.Net on MSNPhase 1 trial examines safety and feasibility of stem cell treatment for Parkinson'sA recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem ...
Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...
Patients enroll in phase 2 oncology trials seeking access to promising new treatments, but the risk-benefit assessments and ...
The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...
We think it can be appropriate to present phase 2 trial participation as offering a small prospect of benefit,” researchers wrote. About 16% of patients enrolled in phase 2 cancer trials receive a ...
For more information on the Phase 1b clinical trial, visit: https://clinicaltrials.gov/study/NCT06732180 ...
A recently launched Phase 1 clinical trial at Mass General Brigham is examining ... trial of an autologous stem cell transplant, based on research and technologies invented and validated ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results